Source: magnific.com Ask ten UK traders which broker is best and you'll get a range of answers, because the "best" broker genuinely depends on how someone trades. But when you assess brokers against the criteria that matter most to the widest range of UK traders — regulation, track record, execution quality, platform choice and market [...]
The disposal was executed under a pre-established Rule 10b5-1 trading plan adopted in August 2025, reducing the insider's direct stake to 56,858 shares.
Ciena (NYSE:CIEN) outlined financial objectives through fiscal 2029, including a target of approximately $14 billion in revenue, gross margins of about 50%, and operating margins of 32% to 35%, as the company expects demand for optical systems and interconnect products to continue outpacing industry
Nearly all of the gain arrived in the past 12 months. What was behind it is the same factor that cost the memory producer $5.8 billion three years ago.
Arrowhead Pharmaceuticals (NASDAQ:ARWR) is expanding its commercial and clinical footprint around RNA interference therapies, with its recently launched triglyceride-lowering treatment REDEMPLO and several pipeline programs targeting cardiometabolic disease, obesity and central nervous system disord
Given its solid financial performance, favourable growth prospects, and a reasonable valuation, the uptrend in CES Energy is set to continue, making it an excellent long-term buy.
This under-the-radar industrial technology stock boasts a Superscore of 88 from our Hidden Gems Primary database, part of The Motley Fool's Moneyball Database system. Here's why.
Ford is paying a dividend while its turnaround plays out. Stellantis is still working toward positive free cash flow and doesn't expect to get there until 2027. The difference in financial footing tells the whole story.
